SCHEMBL8538348

SCHEMBL8538348

CCc1ccc2c(c1)c(-c1ccccc1Cl)c(N)c(=O)n2C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.42
RORA P35398 1/20 0.42
RORC P51449 1/20 0.42
RORB Q92753 1/20 0.42
MAPT P10636 3/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
KMT2A Q03164 1/20 0.41
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
DPP4 P27487 1/20 0.39
DPP8 Q6V1X1 1/20 0.39
PTGES O14684 2/20 0.38
CHEK1 O14757 2/20 0.38
WEE1 P30291 2/20 0.38
CYP2C9 P11712 1/20 0.38
LMNA P02545 2/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8543014 0.85 KDM4E (0.44) MAPTALDH1A1KDM4EMEN1USP2
SCHEMBL8539176 0.84 KDM4E (0.43) MAPTALDH1A1KDM4EMEN1USP2
SCHEMBL9358757 0.83 EDNRB (0.42) PGRRORARORCRORBMAPT
SCHEMBL8541594 0.81 KDM4E (0.44) RORARORCRORBMAPTALDH1A1
SCHEMBL9359243 0.80 ALDH1A1 (0.53) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL9359195 0.80 CYP1A1 (0.43) MAPTALDH1A1KDM4EMEN1USP2
SCHEMBL30574986 0.76 WEE1 (0.44) MAPTALDH1A1KDM4EMEN1USP2
SCHEMBL9359150 0.73 PKM (0.46) KDM4EKMT2ALMNANPC1POLB
SCHEMBL8542241 0.72 MAPT (0.36) MAPTKDM4EMEN1KMT2APTGES
SCHEMBL9359114 0.72 S1PR4 (0.41) MAPTALDH1A1MEN1KMT2ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0623112-B1 4-Phenyl-3-(heteroarylureido)-1,2-dihydro-2-oxoquinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents PFIZER (US) 1998-12-30 EP disclosed
US-5565472-A 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents PFIZER INC. (US) 1996-10-15 US disclosed
WO-1993015058-A1 4-ARYL-3-(HETEROARYLUREIDO)-1,2-DIHYDRO-2-OXO-QUINOLINE DERIVATIVES AS ANTIHYPERCHOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS PFIZER INC. (US) 1993-08-05 WO disclosed